Endovastec(SH:688016) Sou Hu Cai Jing·2025-05-06 12:50Company Overview - Shanghai MicroPort CardioFlow Medtech Co., Ltd. specializes in the research, production, and sales of interventional medical devices for aortic and peripheral blood vessels [2] - The main products include thoracic aortic stent graft systems, abdominal aortic stent graft systems, intraoperative stents, balloon catheters, and stents [2] - The company has received several awards, including the Shanghai Government Quality Gold Award and recognition as one of the top 30 value companies on the Sci-Tech Innovation Board [2] Financial Performance - For Q1 2025, the company reported revenue of 332 million yuan, a year-on-year decrease of 7.23% [2] - The net profit for the same period was 130 million yuan, down 29.66% year-on-year, with a gross profit margin of 69.61% [2] Market Position - As of May 6, the company's stock closed at 86.03 yuan, with a PE ratio of 23.70 times, and a total market capitalization of 10.604 billion yuan [1] - The average PE ratio in the medical device industry is 48.90 times, with a median of 36.41 times, placing the company at the 52nd position in the industry ranking [1][3] Shareholder Information - As of March 31, 2025, the number of shareholders reached 18,176, an increase of 523 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]